Daniel Bartfeld

1.2k total citations
16 papers, 827 citations indexed

About

Daniel Bartfeld is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Biotechnology. According to data from OpenAlex, Daniel Bartfeld has authored 16 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Health, Toxicology and Mutagenesis and 3 papers in Biotechnology. Recurrent topics in Daniel Bartfeld's work include Transgenic Plants and Applications (3 papers), Environmental Toxicology and Ecotoxicology (3 papers) and Myasthenia Gravis and Thymoma (2 papers). Daniel Bartfeld is often cited by papers focused on Transgenic Plants and Applications (3 papers), Environmental Toxicology and Ecotoxicology (3 papers) and Myasthenia Gravis and Thymoma (2 papers). Daniel Bartfeld collaborates with scholars based in Israel and Canada. Daniel Bartfeld's co-authors include Sara Fuchs, Yoseph Shaaltiel, Einat Brill‐Almon, Sharon Hashmueli, David Aviezer, Gad Galili, Orly Dym, Swetlana Boldin‐Adamsky, Joel L. Sussman and Anthony H. Futerman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Biotechnology and PLoS ONE.

In The Last Decade

Daniel Bartfeld

16 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Bartfeld Israel	12	566	377	146	125	88	16	827
Thomas Dalik Austria	11	467 0.8×	113 0.3×	38 0.3×	97 0.8×	58 0.7×	12	664
Maurice Wong United States	18	480 0.8×	76 0.2×	47 0.3×	69 0.6×	32 0.4×	36	658
Γεώργιος Σκρέτας Greece	19	782 1.4×	147 0.4×	32 0.2×	19 0.2×	124 1.4×	41	947
Hideko Ishihara Japan	10	528 0.9×	160 0.4×	53 0.4×	102 0.8×	96 1.1×	28	713
Zhuji Fu United States	21	713 1.3×	50 0.1×	57 0.4×	215 1.7×	13 0.1×	26	1.3k
F. D. Ziegler United States	13	361 0.6×	50 0.1×	99 0.7×	65 0.5×	43 0.5×	22	573
Manju Basu United States	13	577 1.0×	39 0.1×	92 0.6×	100 0.8×	29 0.3×	35	711
Fernando J. Irazoqui Argentina	14	363 0.6×	38 0.1×	13 0.1×	201 1.6×	130 1.5×	36	557
Xia Zhang China	16	486 0.9×	97 0.3×	59 0.4×	29 0.2×	6 0.1×	49	727
Lanmin Zhai United States	12	383 0.7×	20 0.1×	141 1.0×	57 0.5×	14 0.2×	16	652

Countries citing papers authored by Daniel Bartfeld

Since Specialization

Citations

This map shows the geographic impact of Daniel Bartfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Bartfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Bartfeld more than expected).

Fields of papers citing papers by Daniel Bartfeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Bartfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Bartfeld. The network helps show where Daniel Bartfeld may publish in the future.

Co-authorship network of co-authors of Daniel Bartfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Bartfeld. A scholar is included among the top collaborators of Daniel Bartfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Bartfeld. Daniel Bartfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Tekoah, Yoram, Avidor Shulman, Tali Kizhner, et al.. (2015). Large‐scale production of pharmaceutical proteins in plant cell culture—the protalix experience. Plant Biotechnology Journal. 13(8). 1199–1208. 123 indexed citations

Atsmon, Jacob, Einat Brill‐Almon, Raul Chertkoff, et al.. (2015). Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R. Toxicology and Applied Pharmacology. 287(3). 202–209. 16 indexed citations

Aviezer, David, Einat Brill‐Almon, Yoseph Shaaltiel, et al.. (2009). A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme—A Preclinical and Phase I Investigation. PLoS ONE. 4(3). e4792–e4792. 128 indexed citations

Shaaltiel, Yoseph, Daniel Bartfeld, Sharon Hashmueli, et al.. (2007). Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. Plant Biotechnology Journal. 5(5). 579–590. 277 indexed citations

Bartfeld, Daniel, et al.. (2004). Recombinant antimicrobial peptides efficiently produced using novel cloning and purification processes. Biotechnology and Applied Biochemistry. 39(3). 339–345. 15 indexed citations

Frankenburg, Shoshana, Y. Pinchasov, Olga Drize, et al.. (2004). Production and purification of melanoma gp100 antigen and polyclonal antibodies. Protein Expression and Purification. 34(2). 183–189. 10 indexed citations

Bartfeld, Daniel, et al.. (1994). Purification and characterization of a novel tripeptidyl aminopeptidase from Streptomyces lividans 66. FEBS Letters. 352(3). 385–388. 14 indexed citations

Bartfeld, Daniel, et al.. (1988). Efficient Production of Active Human Manganese Superoxide Dismutase in Escherichia Coli. Nature Biotechnology. 6(8). 930–935. 38 indexed citations

Hartman, John R., et al.. (1986). High-level expression of enzymatically active human Cu/Zn superoxide dismutase in Escherichia coli.. Proceedings of the National Academy of Sciences. 83(19). 7142–7146. 56 indexed citations

10.

Soreq, Hermona, Daniel Bartfeld, Ruti Parvari, & Sara Fuchs. (1982). Increase in the translatable mRNA for acetylcholine receptor during embryonic development of Torpedo ocellata electric organ. FEBS Letters. 139(1). 32–36. 5 indexed citations

11.

Fuchs, Sara, et al.. (1981). ACETYLCHOLINE RECEPTOR: MOLECULAR DISSECTION AND MONOCLONAL ANTIBODIES IN THE STUDY OF EXPERIMENTAL MY ASTHENIA *. Annals of the New York Academy of Sciences. 377(1). 110–124. 19 indexed citations

12.

Fuchs, Sara, Daniel Bartfeld, Zelig Eshhar, et al.. (1980). Immune regulation of experimental myasthenia.. Journal of Neurology Neurosurgery & Psychiatry. 43(7). 634–643. 7 indexed citations

13.

Bartfeld, Daniel & Sara Fuchs. (1979). Active acetylcholine receptor fragment obtained by tryptic digestion of acetylcholine receptor from Torpedo californica. Biochemical and Biophysical Research Communications. 89(2). 512–519. 28 indexed citations

14.

Bartfeld, Daniel & Sara Fuchs. (1979). Fractionation of antibodies to acetylcholine receptor according to antigenic specificity. FEBS Letters. 105(2). 303–306. 9 indexed citations

15.

Bartfeld, Daniel & Sara Fuchs. (1978). Specific immunosuppression of experimental autoimmune myasthenia gravis by denatured acetylcholine receptor.. Proceedings of the National Academy of Sciences. 75(8). 4006–4010. 41 indexed citations

16.

Bartfeld, Daniel & Sara Fuchs. (1977). Immunological characterization of an irreversibly denatured acetylcholine receptor. FEBS Letters. 77(2). 214–218. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact